Ignite Creation Date:
2024-05-05 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 9:56 AM
Study NCT ID:
NCT00768053
Status:
COMPLETED
Last Update Posted:
2011-07-29
First Post:
2008-10-03
Brief Title:
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
Open-Label Study To Evaluate The EULAR-RAID Score Rheumatoid Arthritis Impact Of Disease Score In Rheumatoid Arthritis Patients Eligible To Etanercept And Who Will Receive Etanercept
Status:
COMPLETED
Status Verified Date:
2011-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Rainbow
Brief Summary:
The Disease Activity Score DAS is a system of measurement developed in the 1980s that uses certain criteria including joint counts and patient perceived disease activity to measure disease activity in people with Rheumatoid Arthritis More recently the European League against Rheumatism EULAR has developed a new system of measurement known as the Rheumatoid Arthritis Impact of Disease score or EULAR-RAID score The EULAR-RAID score is a composite score based on patient reported outcomes and includes such criteria as pain functional disability fatigue sleep disturbances coping overall assessment of physical well being and overall assessment of psychological well being The objective of this study is to evaluate the practical modalities and performance of the EULAR- RAID score in patients with rheumatoid arthritis who have been prescribed etanercept as part of usual medical practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| B1801019 | None | None | None |